ResMed Inc. (RMD) is considered one of the best medical technology stocks to invest in. KeyBanc Capital Markets raised the price target on ResMed to $302 and maintained an Overweight rating. The firm praised ResMed’s Q2 revenue exceeding expectations, driven by strength in Masks & Accessories and Devices businesses.

RBC Capital Markets also raised ResMed’s price target to $314 from $311 after strong quarterly results. The company saw double-digit revenue and earnings growth, with solid performance across markets and improving margins. RBC kept an Outperform rating, highlighting ResMed’s earnings outlook and potential shareholder returns.

ResMed Inc. (NYSE:RMD) develops medical devices and digital health solutions for respiratory conditions. Its products include CPAP machines, masks, and cloud-connected software platforms for remote patient monitoring. While ResMed shows promise as an investment, some AI stocks may offer greater upside potential with less downside risk.

For more insights on foreign stocks and AI penny stocks, visit Insider Monkey. This article is originally published on their website.

Read more at Yahoo Finance: ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings